J&J, Novartis Fined $22.4M Over Pay-For-Delay Deal
Drugmakers Johnson & Johnson and Novartis AG on Tuesday were hit with a total of €16.3 million ($22.4 million) in fines by European regulators for entering into an anti-competitive agreement to...To view the full article, register now.
Already a subscriber? Click here to view full article